Published in J Biol Chem on August 30, 2004
The tyrosine kinase network regulating mast cell activation. Immunol Rev (2009) 2.29
New insights on mast cell activation via the high affinity receptor for IgE. Adv Immunol (2008) 1.51
Positive and negative regulation of mast cell activation by Lyn via the FcepsilonRI. J Immunol (2005) 1.25
The Src family kinase Hck regulates mast cell activation by suppressing an inhibitory Src family kinase Lyn. Blood (2007) 1.24
Quantitative time-resolved phosphoproteomic analysis of mast cell signaling. J Immunol (2007) 1.16
Cholesterol deficiency in a mouse model of Smith-Lemli-Opitz syndrome reveals increased mast cell responsiveness. J Exp Med (2006) 1.05
Adapters in the organization of mast cell signaling. Immunol Rev (2009) 1.03
Quantitative nanoscale analysis of IgE-FcεRI clustering and coupling to early signaling proteins. J Phys Chem B (2012) 1.01
Differential dephosphorylation of the FcRgamma immunoreceptor tyrosine-based activation motif tyrosines with dissimilar potential for activating Syk. J Biol Chem (2008) 0.87
The MS4A family: counting past 1, 2 and 3. Immunol Cell Biol (2015) 0.86
Mast cells in airway diseases and interstitial lung disease. Eur J Pharmacol (2015) 0.79
An Interaction Library for the FcεRI Signaling Network. Front Immunol (2014) 0.79
Involvement of Fc(epsilon)R1beta gene polymorphisms in susceptibility to atopy in Korean children with asthma. Eur J Pediatr (2009) 0.78
Fcepsilon- and Fcgamma-receptor signaling in diseases. Springer Semin Immunopathol (2006) 0.75
Arsenic inhibits mast cell degranulation via suppression of early tyrosine phosphorylation events. J Appl Toxicol (2016) 0.75
Rethinking the role of immunoglobulin E and its high-affinity receptor: new insights into allergy and beyond. Int Arch Allergy Immunol (2014) 0.75
Exon skipping of FcεRIβ eliminates expression of the high-affinity IgE receptor in mast cells with therapeutic potential for allergy. Proc Natl Acad Sci U S A (2016) 0.75
Amplification of CRAC current by STIM1 and CRACM1 (Orai1). Nat Cell Biol (2006) 6.31
CRACM1 multimers form the ion-selective pore of the CRAC channel. Curr Biol (2006) 6.02
Defective mast cell effector functions in mice lacking the CRACM1 pore subunit of store-operated calcium release-activated calcium channels. Nat Immunol (2007) 3.57
New developments in FcepsilonRI regulation, function and inhibition. Nat Rev Immunol (2007) 2.99
Observational fear learning involves affective pain system and Cav1.2 Ca2+ channels in ACC. Nat Neurosci (2010) 2.57
BTK regulates PtdIns-4,5-P2 synthesis: importance for calcium signaling and PI3K activity. Immunity (2003) 2.02
Calcium signaling in immune cells. Nat Immunol (2009) 1.97
TRPM4 regulates calcium oscillations after T cell activation. Science (2004) 1.74
Molecular clustering of STIM1 with Orai1/CRACM1 at the plasma membrane depends dynamically on depletion of Ca2+ stores and on electrostatic interactions. Mol Biol Cell (2008) 1.72
Gain-of-function mutations in the extracellular domain of KIT are common in canine mast cell tumors. Mol Cancer Res (2008) 1.31
TRPM4 controls insulin secretion in pancreatic beta-cells. Cell Calcium (2006) 1.27
The long and arduous road to CRAC. Cell Calcium (2007) 1.21
A pyrazole derivative potently inhibits lymphocyte Ca2+ influx and cytokine production by facilitating transient receptor potential melastatin 4 channel activity. Mol Pharmacol (2006) 1.13
Critical role of the neutrophil-associated high-affinity receptor for IgE in the pathogenesis of experimental cerebral malaria. J Exp Med (2011) 1.13
Discrimination of intracellular calcium store subcompartments using TRPV1 (transient receptor potential channel, vanilloid subfamily member 1) release channel activity. Biochem J (2003) 1.12
Phase II study of oral masitinib mesilate in imatinib-naïve patients with locally advanced or metastatic gastro-intestinal stromal tumour (GIST). Eur J Cancer (2010) 1.11
The calcium-activated nonselective cation channel TRPM4 is essential for the migration but not the maturation of dendritic cells. Nat Immunol (2008) 1.10
Pillars article: Recruitment of tyrosine phosphatase HCP by the killer cell inhibitory receptor. Immunity. 1996. 4: 77-85. J Immunol (2013) 1.07
Cotranslational endoplasmic reticulum assembly of FcepsilonRI controls the formation of functional IgE-binding receptors. J Exp Med (2005) 1.03
The role of the FcepsilonRI beta-chain in allergic diseases. Int Arch Allergy Immunol (2004) 1.03
Competing functions encoded in the allergy-associated F(c)epsilonRIbeta gene. Immunity (2003) 1.02
Uncovering new complexities in mast cell signaling. Nat Immunol (2002) 0.97
Masitinib as an adjunct therapy for mild-to-moderate Alzheimer's disease: a randomised, placebo-controlled phase 2 trial. Alzheimers Res Ther (2011) 0.96
Safety and activity of masitinib in combination with gemcitabine in patients with advanced pancreatic cancer. Cancer Chemother Pharmacol (2010) 0.93
Trichuris suis ova: testing a helminth-based therapy as an extension of the hygiene hypothesis. J Allergy Clin Immunol (2012) 0.92
Serum IgE clearance is facilitated by human FcεRI internalization. J Clin Invest (2014) 0.92
Anti-CD63 antibodies suppress IgE-dependent allergic reactions in vitro and in vivo. J Exp Med (2005) 0.92
No monkey business: why studying NK cells in non-human primates pays off. Front Immunol (2013) 0.91
The TRPM4 channel controls monocyte and macrophage, but not neutrophil, function for survival in sepsis. J Immunol (2012) 0.86
Role of the extracellular domain of Fc epsilon RI alpha in intracellular processing and surface expression of the high affinity receptor for IgE Fc epsilon RI. Mol Immunol (2008) 0.83
The tetraspanin CD63 is required for efficient IgE-mediated mast cell degranulation and anaphylaxis. J Immunol (2013) 0.83
[The high-affinity IgE receptor: lessons from structural analysis]. Med Sci (Paris) (2003) 0.77